Search results
Results from the WOW.Com Content Network
Aldous Huxley, author of Brave New World, became a user of psychedelics after moving to Hollywood. He was at the forefront of the counterculture's use of psychedelic drugs, which led to his 1954 work The Doors of Perception. Dying from cancer, he asked his wife on 22 November 1963 to inject him with 100 μg of LSD. He died later that day. [261]
Learn more about the potential downsides of taking psychedelics such as "magic mushrooms ... voters approved legalization in 2022 — some psychedelic researchers worry the dangers are ...
Psychedelic therapy (or psychedelic-assisted therapy) refers to the proposed use of psychedelic drugs, such as psilocybin, ayahuasca, ...
Psychedelic therapy (or psychedelic-assisted therapy) refers to the proposed use of psychedelic drugs, such as psilocybin, MDMA, [note 2] LSD, and ayahuasca, to treat mental disorders. [ 58 ] [ 59 ] As of 2021, psychedelic drugs are controlled substances in most countries and psychedelic therapy is not legally available outside clinical trials ...
“Psychedelics are really powerful,” said Emily Oneschuk, the grassroots campaign director for MMHO. ... Other professionals highlighted the lack of research in certain areas and dangers of ...
Psychedelic microdosing is the practice of using sub-threshold doses of psychedelics in an attempt to improve creativity, boost physical energy level, emotional balance, increase performance on problems-solving tasks and to treat anxiety, depression and addiction.
Psychedelics, including psilocybin, have been shown to affect different clusters of brain regions known as the "theory of mind network" (ToMN) and the default mode network (DMN). [60] The ToMN involves making inferences and understanding social situations based on patterns [ 61 ] whereas, the DMN relates more to introspection and one's sense of ...
More rarely, psychedelic experiences can include complex hallucinations of objects, animals, people, or even whole landscapes. [13] A number of studies by Roland R. Griffiths and other researchers have concluded that high doses of psilocybin and other classic psychedelics trigger mystical experiences in most research participants.